An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Growth and Innovation Division at Magellan Health Announces New Appointments for Alisa Bahl, Ph.D. and Sean Gregory, Ph.D.
Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Magellan Health, Inc. (NASDAQ: MGLN) has appointed Dr. Alisa Bahl as chief of strategy and innovation and Dr. Sean Gregory as senior vice president of analytics and insight. Both leaders bring extensive healthcare experience and will focus on integrating behavioral and physical health. Dr. Bahl aims to enhance strategies across business segments, while Dr. Gregory will utilize insights for product development. The appointments are part of Magellan's commitment to improving health and wellbeing solutions for complex healthcare needs.
Positive
Appointment of Dr. Alisa Bahl as chief of strategy and innovation to enhance business strategies.
Dr. Sean Gregory's expertise in analytics will support product development initiatives.
Negative
None.
PHOENIX--(BUSINESS WIRE)--
Magellan Health, Inc. (NASDAQ: MGLN) today announced it has appointed Alisa Bahl, Ph.D., as chief of strategy and innovation for Magellan Health, and Sean Gregory, Ph.D. as senior vice president of analytics and insight for Magellan Health.
“We welcome Alisa and Sean, two accomplished healthcare leaders, to Magellan Health’s Growth and Innovation team, and look forward to leveraging their extensive clinical, managed care and research expertise to address complex healthcare needs,” said Tim Lacy, chief growth officer, Magellan Health. “Alisa and Sean share our commitment to pursue the intersection of behavioral health and physical health and accelerate Magellan’s vision to re-imagine the health and wellbeing experiences of Americans through the development of relevant and progressive high-touch and high-tech clinical solutions that address the needs of life, mind and body.”
As chief of strategy and innovation, Dr. Bahl will advance strategies and align priorities across the Behavioral and Specialty Health and Federal business segments. She will also collaborate with key internal and external partners to further the development of products and services that address those most significantly impacted by chronic health and complex wellbeing challenges. Dr. Bahl earned her bachelor’s degree from the University of Florida and a Ph.D. in clinical psychology from the University of Miami. Most recently, Dr. Bahl served as Magellan’s senior vice president of clinical alliances and as chief strategy officer for Magellan Healthcare, the behavioral and specialty healthcare segment of Magellan Health.
In his newly appointed role, Dr. Gregory will partner closely with key stakeholders to leverage new insights critical to product development. Dr. Gregory has extensive experience in healthcare with a primary research emphasis focused on behavioral health, as well as the integration of physical and behavioral health leveraging comparative effectiveness, cost-effectiveness techniques, and large integrated data. In addition, Dr. Gregory conducts policy analyses and program evaluations of various local, state, and federal health programs. Dr. Gregory earned his Ph.D. and master’s degree in Health Services Research, Policy, and Administration from the University of Minnesota, Twin Cities, and his MBA and bachelor’s degree from The Florida State University.
About Magellan Health: Magellan Health, Inc., is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan's customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators. For more information, visit MagellanHealth.com.
Who are the new executives appointed at Magellan Health, Inc. (MGLN)?
Magellan Health has appointed Dr. Alisa Bahl as chief of strategy and innovation and Dr. Sean Gregory as senior vice president of analytics and insight.
What is the role of Dr. Alisa Bahl at Magellan Health?
Dr. Alisa Bahl will advance strategies and align priorities across the Behavioral and Specialty Health and Federal business segments.
What expertise does Dr. Sean Gregory bring to Magellan Health?
Dr. Sean Gregory has extensive experience in behavioral health research and will leverage insights for product development.
How will the new appointments impact Magellan Health (MGLN)?
The new appointments aim to enhance the integration of behavioral and physical health and improve healthcare solutions.
